Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Arthritis / November 2007

Tip: Looking for answers? Try searching our database.

Something Is Inhibiting The Disc Repair Process

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
ironjustice@aol.com - 02 Nov 2007 13:41 GMT
Stem Cells Found In Degenerating Spinal Discs
Main Category: Bones / Orthopaedics News
Article Date: 02 Nov 2007 - 5:00 PDT

Orthopedic researchers at Jefferson Medical College have for the first
time found stem cells in the intervertebral discs of the human spine,
suggesting that such cells might someday be used to help repair
degenerating discs and remedy lower back and neck pain.

Reporting November 1, 2007 in the journal Spine, a team led by
Makarand Risbud, Ph.D., and Irving Shapiro, Ph.D., at Jefferson
Medical College of Thomas Jefferson University in Philadelphia, have
found stem cells in both degenerated adult human discs and in discs of
animals.

Many people suffer from lower back pain, and treatment ranges from
painkillers such as acetominophen to medical procedures, such as
fusing vertebrae. The combined annual costs for treatment of back pain
and disc disease is approximately $100 billion a year and a major
cause of lost work in the United States.

According to Dr. Shapiro, as the discs in the spine degenerate, cells
are lost and the ability to produce water-binding molecules called
proteoglycans is decreased. The water absorbs forces on the spine,
essentially serving as shock absorbers. Losing proteoglycans can
result in damage to the disc, and sometimes, pain.

"It would be wonderful if we could get the cells in the intervertebral
disc to regenerate or increase the amount of proteoglycans that they
synthesize," he says. "That way we could regenerate the shock-
absorbing capabilities of the spine."

Dr. Risbud, an assistant professor of Orthopedic Surgery, and Dr.
Shapiro, who is professor of Orthopedic Surgery, both at Jefferson
Medical College, and their co-workers asked if it was possible to
regenerate proteoglycans using adult stem cells. Federal regulations
prevent them from using embryonic stem cells.

Dr. Risbud built the study around the observation that while the
tissue that he could isolate from the disc was no longer binding
water, the tissue still might contain dormant stem cells. He thought
that while these cells were no longer functioning to repair the
damaged disc, under appropriate conditions, they could be activated.

To explore that possibility, he isolated cells from discarded disc
tissue that still had the capacity to proliferate. Dr. Risbud notes
that under certain conditions, the cells could be encouraged to form
bone. In other conditions, the cells would form cartilage or even fat.
The tests proved that these cells were indeed dormant disc stem cells.
"If we are able to stimulate the 'silent' cells in the patient, then
it may be possible to repair the ravages of degenerative disc disease
without undergoing invasive surgical procedures that may limit the
motion of the spine," he says.

According to Dr. Risbud, in earlier work, the researchers found that
local conditions in the disc can promote adult stem cells of the bone
marrow to acquire characteristics of disc cells. Within the disc, the
local conditions are unique in that the oxygen levels are low. These
conditions cause the expression of many specialized molecules,
including the water-binding proteoglycans. Some of the researchers'
current experiments focus on the use of adult stem cells to repair the
degenerate intervertebral disc.

Shapiro notes that other researchers have taken bone marrow stem cells
and have made new bone, cartilage and fat tissue. "Our next step is to
activate these disc stem cells and get them to repopulate the disc and
make proteoglycans and restore the water-binding,

The scientists theorize that because the stem cells exist in the
degenerate disk, there may be molecules that are blocking stem cell
activity. "Something is inhibiting the disc repair process," says Dr.
Shapiro. Drs. Shapiro and Risbud agree that "new studies are needed to
discover the nature of such inhibitory molecules" and to find ways to
block their activities, promoting natural healing.

----------------------------
Article adapted by Medical News Today from original press release.

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com

Man Is A Herbivore!
http://tinyurl.com/a3cc3

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
Taka - 02 Nov 2007 16:39 GMT
On Nov 2, 9:41 pm, "ironjust...@aol.com" <ironjust...@aol.com> wrote:
> Stem Cells Found In Degenerating Spinal Discs
> Main Category: Bones / Orthopaedics News
[quoted text clipped - 6 lines]
> discover the nature of such inhibitory molecules" and to find ways to
> block their activities, promoting natural healing.

These molecules may be in fact the omega-6 fatty acids like AA which
some researchers consider essential.  Notice that the healthy and
young cartilage has the Mead acid in it which can be manufactured by
the body even from carbohydrates:

FASEB J. 1991 Mar 1;5(3):344-53.

Unique fatty acid composition of normal cartilage: discovery of high
levels of n-9 eicosatrienoic acid and low levels of n-6
polyunsaturated fatty acids.

Adkisson HD 4th, Risener FS Jr, Zarrinkar PP, Walla MD, Christie WW,
Wuthier RE.
Department of Chemistry, University of South Carolina, Columbia 29208.

We report here the finding that normal, young cartilages, in
distinction from all other tissues examined, have unusually high
levels of n-9 eicosatrienoic (20:3 cis-delta 5,8,11) acid and low
levels of n-6 polyunsaturated fatty acids (n-6 PUFA). This pattern is
identical to that found in tissues of animals subjected to prolonged
depletion of nutritionally essential n-6 polyunsaturated fatty acids
(EFA). This apparent deficiency is consistently observed in cartilage
of all species so far studied (young chicken, fetal calf, newborn pig,
rabbit, and human), even though levels of n-6 PUFA in blood and all
other tissues is normal. The n-9 20:3 acid is particularly abundant in
phosphatidylethanolamine, phosphatidylinositol, and the free fatty
acid fractions from the young cartilage. Several factors appear to
contribute to the reduction in n-6 PUFA and the appearance of high
levels of the n-9 20:3 acid in cartilage: 1) limited access to
nutritional sources of EFA due to the impermeability and avascularity
of cartilage, 2) rapid metabolism of n-6 PUFA to prostanoids by
chondrocytes, and 3) a unique fatty acid metabolism by cartilage.
Evidence is presented that each of these factors contributes.
Previously, EFA deficiency has been shown to greatly suppress the
inflammatory response of leukocytes and rejection of tissues
transplanted into allogeneic recipients. Because eicosanoids, which
are derived from EFA, have been implicated in the inflammatory
responses associated with arthritic disease, reduction of n-6 PUFA and
accumulation of the n-9 20:3 acid in cartilage may be important for
maintaining normal cartilage structure.

Mead acid synthesis (requires VitB6):
http://www.lipomics.com/fatty_acids/5-8-11-eicosatrienoic-acid

Taka
monty1945@lycos.com - 02 Nov 2007 23:27 GMT
This sounds like a good study I cited on my site, which found butter
to help in the bone growth process but corn oil to be inhibitive.
Many "diseases" that exist now to a much greater degree than in the
past seem to be due to the excessive free radical activity (mostly in
vivo lipid peroxidation), which is due especially to the use of highly
refined and unsaturated oils.
Taka - 03 Nov 2007 04:00 GMT
On Nov 3, 7:27 am, monty1...@lycos.com wrote:
> This sounds like a good study I cited on my site, which found butter
> to help in the bone growth process but corn oil to be inhibitive.
> Many "diseases" that exist now to a much greater degree than in the
> past seem to be due to the excessive free radical activity (mostly in
> vivo lipid peroxidation), which is due especially to the use of highly
> refined and unsaturated oils.

It's also interesting that the best herb used for treating arthritis
is a specific 5-lipoxygenase (5-LOX) inhibitor.  This enzyme makes
leukotrienes from the arachidonic acid (AA).  These leukotrienes like
LTB4 are very powerful tissue destructors via proteolysis.  Also note
that the cysteinyl leukotrienes are responsible for allergies and
asthma.  If Mead acid is used instead of AA as a substrate for 5-LOX,
a less reactive leukotriene LTA3 is made which may have just the right
amount of activity for a brief proteolytic pulse to clean the debris
in a wound before the rebuilding process driven by prostaglandins
starts.  With the AA metabolites, the tissue may be permanently stuck
in the original destructive phase of inflammation ...  For people with
AA in the cartilage it may be difficult to replace it with the Mead
acid by simple diet since the cartilage has no blood supply and very
low tissue turnover.  However, this may help when manufacturing the
cartilage for tissue engineering in vitro since it's easy to make the
cells in a culture "EFAD" and tissues with no AA in them are
immunologically very suitable for transplants (no rejection due to AA-
driven inflammation).

Taka

About the 5-LOX inhibitor Boswellia serrata:
http://tinyurl.com/2wcfeu
ironjustice - 10 Nov 2007 18:48 GMT
>> On Nov 2, 7:00 pm, Taka <taka0...@gmail.com> wrote: For people with
AA in the cartilage it may be difficult to replace it with the Mead
acid by simple diet since the cartilage has no blood supply and very
low tissue turnover. <<

WILL mead acid displace arachidonic acid (AA) .. ? / "it may be
difficult to replace it with the Mead acid" .. ?

One might think of going with those fatty acids KNOWN to displace ..
arachidonic acid (AA).
Vegetarian diet is all but DEVOID of .. arachidonic acid (AA).
Vegetarian diet .. supplies the fatty-acid SHOWN to displace
arachidonic acid (AA) .

"dihomo-gamma- linolenic acid (DGLA) can displace arachidonic acid"

Prostaglandins Leukot Essent Fatty Acids. 1998 Mar;58(3):185-91.
Links
Dietary alpha-linolenic acid increases TNF-alpha, and decreases IL-6,
IL-10 in response to LPS: effects of sesamin on the delta-5
desaturation of omega6 and omega3 fatty acids in mice.
Chavali SR, Zhong WW, Forse RA.
Department of Surgery, Harvard Institute of Medicine, Beth Israel
Deaconess Medical Center and Harvard Medical School, Boston, MA
02215,
USA.

Sesamin (a non-fat portion of sesame seed oil) inhibits delta-5
desaturase activity resulting in an accumulation of dihomo-gamma-
linolenic acid (DGLA) which can displace arachidonic acid (AA) and
decrease the formation of pro-inflammatory mediators. We investigated
the effects of consumption of diets containing 0.25wt% sesamin and 15
wt% safflower oil (SO) (providing 12% of the added fat as linoleic
acid) or a 15 wt% 2:1 mixture of linseed oil and SO (LOSO) (providing
6% alpha-linolenic acid and 6% linoleic acid) for 3 weeks on the
liver
membrane fatty acid composition and on the production of
prostaglandin
(PG) E2, TNF-alpha, IL-6 and IL10 in mice. Consumption of sesamin-
supplemented SO and LOSO diets resulted in a significant increase in
the levels of 20:3omega6 (DGLA), suggesting that sesamin inhibited
delta-5 desaturation of omega6 fatty acids. In animals fed LOSO
diets,
the levels of alpha-linolenic acid, eicosapentaenoic acid (EPA) and
of
docosahexaenoic acid (DHA) were elevated with a concomitant decrease
of arachidonic acid (AA) in the liver membrane phospholipids.
Further,
in animals fed LOSO diets with or without sesamin, an increase in the
circulating levels of TNF-alpha was associated with a concomitant
decrease in PGE2. Despite a lack of differences in the levels of AA,
the PGE2 levels were significantly lower in mice fed sesamin-
supplemented SO compared to those fed SO alone. Thus, these data
suggest that irrespective of the availability of a specific fatty
acid
as a substrate, through regulating the PGE2 synthesis, the production
of TNF-alpha could be modulated.

PMID: 9610840 [PubMed - indexed for MEDLINE]

---------------------------------

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com

Man Is A Herbivore!
http://tinyurl.com/a3cc3

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

> On Nov 3, 7:27 am, monty1...@lycos.com wrote:
>
[quoted text clipped - 27 lines]
>
> About the 5-LOX inhibitor Boswellia serrata:http://tinyurl.com/2wcfeu
ironjustice - 10 Nov 2007 22:32 GMT
>> On Nov 2, 7:00 pm, Taka <taka0...@gmail.com> wrote: It's also interesting that the best herb used for treating arthritis
is a specific 5-lipoxygenase (5-LOX) inhibitor. <<

Seems the .. 5-lipoxygenase inhibitor Zileuton .. "reportedly inhibits
5-LO via iron chelation" ..

Those short-chain fatty acids contain .. phytic acid .. another
premiere iron binder / chelator.

Lipoxygenase Inhibitors as Potential Cancer Chemopreventives ... -
2:43pmZileuton reportedly inhibits 5-LO via iron chelation but is
devoid of 12- and 15-LO inhibitory activity (146) . After extensive
clinical evaluation, ...
cebp.aacrjournals.org/cgi/content/full/8/5/467?
maxtoshow=&HITS=&hits=&RESULTFORMAT=&fullt... - Similar pages - Note
this

http://en.wikipedia.org/wiki/Zileuton
Zileuton (INN) is an asthma drug. It blocks leukotriene synthesis by
inhibiting 5-lipoxygenase, an enzyme of the eicosanoid synthesis
pathway.

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com

Man Is A Herbivore!
http://tinyurl.com/a3cc3

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

> On Nov 3, 7:27 am, monty1...@lycos.com wrote:
>
[quoted text clipped - 27 lines]
>
> About the 5-LOX inhibitor Boswellia serrata:http://tinyurl.com/2wcfeu
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.